BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakamura Y, Ishizuki S, Iwasaki R, Okiyama N, Ishitsuka Y, Matsumura Y, Tanaka R, Maruyama H, Watanabe R, Fujisawa Y. Remarkable elevation of fibrinolysis markers and procalcitonin associated with dabrafenib plus trametinib combination therapy: Uncommon adverse events. J Dermatol 2020;47. [DOI: 10.1111/1346-8138.15163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Ayala de Miguel P, Gorospe García I, López Gallego J, Borrega García P. Extreme elevation of acute phase reactants and shock secondary to dabrafenib-trametinib. Melanoma Res 2021;31:268-71. [PMID: 33741812 DOI: 10.1097/CMR.0000000000000733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]